Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI India 2024CPhI India 2024
Not Confirmed
Not Confirmed
26-28 November, 2024
AusBiotech 2024AusBiotech 2024
Not Confirmed
Not Confirmed
30 October-02 November, 2024
Not Confirmed
Not Confirmed
03-06 November, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI India 2024CPhI India 2024
Industry Trade Show
Not Confirmed
26-28 November, 2024
AusBiotech 2024AusBiotech 2024
Industry Trade Show
Not Confirmed
30 October-02 November, 2024
Industry Trade Show
Not Confirmed
03-06 November, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/due-to-its-20-year-mastery-in-micronization-inke-has-emerged-a-cornerstone-in-treating-global-respiratory-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/dmf-filings-hit-all-time-high-in-q3-2024-china-tops-list-with-58-increase-in-type-ii-submissions
09 Nov 2020
// PRESS RELEASE
https://oncoceutics.com/oncoceutics-receives-foundation-grants-to-establish-an-expanded-access-program-for-onc201/#:~:text=Philadelphia%2C%20PA%20(November%205%2C,ONC201%20in%20the%20United%20States.
28 Oct 2020
// PRESS RELEASE
https://oncoceutics.com/oncoceutics-begins-clinical-trial-with-next-generation-imipridone-onc206-at-the-nih/
13 Oct 2020
// PRESS RELEASE
https://oncoceutics.com/oncoceutics-expands-ip-portfolio-with-additional-patents-for-onc201-and-onc212/
30 May 2020
// ONCOCEUTICS
https://oncoceutics.com/oncoceutics-to-present-additional-data-at-asco-showing-clinical-benefit-from-onc201-for-cancer-patients/
01 Apr 2020
// ONCOCEUTICS
https://oncoceutics.com/phase-i-ii-clinical-study-of-onc201-begins-in-japan/
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?